Home LiteratureArticle Details
PMID: 21182263 Published · ppublish English Journal Article Research Support, N.I.H., Intramural

Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Journal of proteome research ·Vol. 10 ·No. 2 ·2011-02-04 ·Pages 479-87

Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J

Abstract

MicroRNA 34a (miR-34a) is a potential tumor suppressor gene and has been identified as a miRNA component of the p53 network. To better understand the biological pathways involved in miR-34a action, a parallel global protein and mRNA expression profiling on miR-34a treated neuroblastoma cells (IMR32) was performed using isotope-coded affinity tags (ICAT) and Affymetrix U133plus2 microarray, respectively. Global profiling showed that miR-34a causes much smaller mRNA expression changes compared to changes at the protein level. A total of 1495 proteins represented by two or more peptides were identified from the quantitative ICAT analysis, of which 143 and 192 proteins are significantly up- or down-regulated by miR-34a, respectively. Pathway analysis of these differentially expressed proteins showed the enrichment of apoptosis and cell death processes in up-regulated proteins but DNA replication and cell cycle processes in the down-regulated proteins. Ribosomal proteins are the most significant set down-regulated by miR-34a. Additionally, biological network analysis to identify direct interactions among the differentially expressed proteins demonstrated that the expression of the ubiquitous transcription factor YY1, as well as its downstream proteins, is significantly reduced by miR-34a. We further demonstrated that miR-34a directly targets YY1 through a miR-34a-binding site within the 3' UTR of YY1 using a luciferase reporter system. YY1 is a negative regulator of p53, and it plays an essential role in cancer biology. Therefore, YY1 is another important direct target of miR-34a which closely regulates TP53 activities.

MeSH Terms
Cell Line, Tumor Gene Expression Profiling Gene Expression Regulation, Neoplastic Genes, Reporter Humans Isotope Labeling MicroRNAs/genetics,metabolism Neuroblastoma/genetics,metabolism Oligonucleotide Array Sequence Analysis Protein Interaction Mapping Proteome/analysis,genetics,metabolism Proteomics Signal Transduction YY1 Transcription Factor/genetics,metabolism
Chemicals
MIRN34 microRNA, human MicroRNAs Proteome YY1 Transcription Factor
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Chen Qing-Rong
Oncogenomics Section, Pediatric Oncology Branch, Advanced Technology Center, National Cancer Institute, Gaithersburg, Maryland 20877, USA.
Yu Li-Rong
Tsang Patricia
Wei Jun S
Song Young K
Cheuk Adam
Chung Joon-Yong
Hewitt Stephen M
Veenstra Timothy D
Khan Javed
References (33)
33 references, click to expand
  1. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.
    Nature. 2005 Feb 17;433(7027):769-73 PMID: 15685193
  2. The guardian's little helper: microRNAs in the p53 tumor suppressor network.
    Cancer Res. 2007 Dec 1;67(23):11099-101 PMID: 18056431
  3. Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma.
    J Proteome Res. 2010 Jan;9(1):373-82 PMID: 19921788
  4. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression.
    Mol Cell Biol. 2006 May;26(9):3565-81 PMID: 16611997
  5. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry.
    Nat Biotechnol. 2001 Oct;19(10):946-51 PMID: 11581660
  6. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Mol Cell. 2007 Jun 8;26(5):731-43 PMID: 17540598
  7. p53-mediated activation of miRNA34 candidate tumor-suppressor genes.
    Curr Biol. 2007 Aug 7;17(15):1298-307 PMID: 17656095
  8. The MYCN oncogene is a direct target of miR-34a.
    Oncogene. 2008 Sep 4;27(39):5204-13 PMID: 18504438
  9. Genome-wide analysis of YY2 versus YY1 target genes.
    Nucleic Acids Res. 2010 Jul;38(12):4011-26 PMID: 20215434
  10. p53 enters the microRNA world.
    Cancer Cell. 2007 Nov;12(5):414-8 PMID: 17996645
  11. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Mol Cell. 2007 Jun 8;26(5):745-52 PMID: 17540599
  12. Evaluation of the acid-cleavable isotope-coded affinity tag reagents: application to camptothecin-treated cortical neurons.
    J Proteome Res. 2004 May-Jun;3(3):469-77 PMID: 15253428
  13. miR-34a repression of SIRT1 regulates apoptosis.
    Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6 PMID: 18755897
  14. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.
    Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7 PMID: 17875987
  15. Proteomics--advances, applications and the challenges that remain.
    Trends Biotechnol. 2002 Dec;20(12 Suppl):S1-2 PMID: 12570151
  16. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
    Proteomics. 2010 Apr;10(8):1557-72 PMID: 20186752
  17. microRNAs join the p53 network--another piece in the tumour-suppression puzzle.
    Nat Rev Cancer. 2007 Nov;7(11):819-22 PMID: 17914404
  18. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Oncogene. 2007 Jul 26;26(34):5017-22 PMID: 17297439
  19. Widespread changes in protein synthesis induced by microRNAs.
    Nature. 2008 Sep 4;455(7209):58-63 PMID: 18668040
  20. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
    Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 PMID: 16199517
  21. Proteomics joins the search for microRNA targets.
    Cell. 2008 Aug 22;134(4):560-2 PMID: 18724926
  22. Characteristics and clustering of human ribosomal protein genes.
    BMC Genomics. 2006 Feb 28;7:37 PMID: 16504170
  23. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12165-70 PMID: 15295102
  24. Neuroblastoma: biological insights into a clinical enigma.
    Nat Rev Cancer. 2003 Mar;3(3):203-16 PMID: 12612655
  25. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
    Mol Cancer Res. 2008 May;6(5):735-42 PMID: 18505919
  26. Causes and consequences of microRNA dysregulation in cancer.
    Nat Rev Genet. 2009 Oct;10(10):704-14 PMID: 19763153
  27. MiR-34, SIRT1 and p53: the feedback loop.
    Cell Cycle. 2009 Mar 1;8(5):712-5 PMID: 19221490
  28. A microRNA component of the p53 tumour suppressor network.
    Nature. 2007 Jun 28;447(7148):1130-4 PMID: 17554337
  29. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis.
    EMBO J. 2001 Mar 15;20(6):1383-93 PMID: 11250904
  30. Identification of miRNA targets with stable isotope labeling by amino acids in cell culture.
    Nucleic Acids Res. 2006;34(16):e107 PMID: 16945957
  31. The impact of microRNAs on protein output.
    Nature. 2008 Sep 4;455(7209):64-71 PMID: 18668037
  32. Yin Yang 1 is a negative regulator of p53.
    Cell. 2004 Jun 25;117(7):859-72 PMID: 15210108
  33. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.
    Oncogene. 2006 Feb 23;25(8):1125-42 PMID: 16314846
Article Info
Journal
Journal of proteome research
Abbr.
J Proteome Res
ISSN
1535-3907
Published
2011-02-04
Epub
2010-00-23
Pages
479-87
Language
English
Region
United States
NLM ID
101128775
PMCID
PMC3679541
Subset
IM
Grants
Intramural NIH HHS · Z99 CA999999 · United States
Intramural NIH HHS · ZIA BC011002-02 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com